United States vascular closure devices market size is projected to exhibit a growth rate (CAGR) of 6.92% during 2024-2032. The growing prevalence of coronary artery and peripheral artery diseases, rising preference for minimally invasive (MI) procedures among patients, and increasing collaborations between manufacturers and healthcare providers represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) | 6.92% |
Vascular closure devices (VCDs) are specialized medical instruments that quickly and safely close the puncture site in a vessel following cardiovascular procedures like angiography or angioplasty. They are manufactured using biocompatible materials, ensuring safety and compatibility with human tissues. They are available in various types, including collagen plug-based, suture-based, and clip-based devices, each suited for specific clinical scenarios. They reduce the discomfort associated with prolonged manual compression at the access site, enhancing the overall experience of patients. They contribute to improved patient outcomes and reduced healthcare costs by minimizing the risk of bleeding complications. They enable healthcare providers to complete procedures more efficiently, reducing procedure time and radiation exposure for both patients and clinicians. They lower complications, which results in shorter hospital stays, leading to cost savings for healthcare facilities. They are utilized in interventional cardiology and radiology, offering an efficient and effective solution for vessel closure.
At present, the rising prevalence of conditions, such as coronary artery disease, peripheral artery disease, and hypertension represents one of the key factors impelling the growth of the market in the United States. Moreover, increasing technological innovations, such as bioabsorbable materials, which reduce the risk of infection and improve biocompatibility and advancements in device design, are contributing to the market growth. This technological progression is not only improving patient outcomes but is also making the devices more appealing to healthcare providers. Besides this, the growing geriatric population that is more susceptible to cardiovascular diseases and requires cardiac interventions like angiography and angioplasty is offering a favorable market outlook in the country. Additionally, rising preferences for minimally invasive (MI) procedures among patients is catalyzing the demand for VCDs to recovery quickly and reduce hospital stays. The increasing awareness about the benefits of VCDs among patients, influenced by digital platforms and patient education programs, is also contributing to the market growth in the country. Apart from this, increasing strategic partnerships and collaborations between VCD manufacturers, healthcare providers, and research institutions are leading to clinical trials, product innovations, and improved training and education programs for healthcare professionals. In addition, the growing integration of digital technologies, including data analytics, artificial intelligence (AI), and machine learning (ML) in healthcare for patient data analysis, is resulting in more personalized care and better decision-making in the use of VCDs. Furthermore, the rising shift towards more patient-centric approaches in device development is encouraging the adoption of VCDs as they minimize pain, reduce anxiety, and accelerate recovery.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, access, procedure, and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes passive approximators (collagen plugs, sealant or gel-based devices, and compression-assist devices), active approximators (suture-based devices and clip-based devices), and external hemostatic devices.
Access Insights:
A detailed breakup and analysis of the market based on the access have also been provided in the report. This includes femoral access and radial access.
Procedure Insights:
The report has provided a detailed breakup and analysis of the market based on the procedure. This includes interventional cardiology and interventional radiology/vascular surgery.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgical centers, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include the Northeast, Midwest, South, and West.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered |
|
Accesses Covered | Femoral Access, Radial Access |
Procedures Covered | Interventional Cardiology, Interventional Radiology/Vascular Surgery |
End Users Covered | Hospitals, Ambulatory Surgical Centers, Others |
Regions Covered | Northeast, Midwest, South, West |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |